Satoru Yamasaki Selected Research

Galactosylceramides (Galactocerebrosides)

1/2024

Tumor epitope spreading by a novel multivalent therapeutic cellular vaccine targeting cancer antigens to invariant NKT-triggered dendritic cells in situ.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Satoru Yamasaki Research Topics

Disease

11	Neoplasms (Cancer) 01/2024 - 03/2003
3	Inflammation (Inflammations) 01/2019 - 04/2006
3	Hypersensitivity (Allergy) 01/2012 - 07/2006
2	Virus Diseases (Viral Diseases) 11/2022 - 10/2016
2	Infections 11/2022 - 10/2016
2	Anaphylaxis (Anaphylactic Shock) 04/2014 - 07/2011
1	Prostatic Neoplasms (Prostate Cancer) 01/2024
1	Multiple Myeloma 06/2023
1	COVID-19 11/2022
1	Testicular Neoplasms (Testicular Cancer) 03/2022
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 03/2020
1	Hematologic Neoplasms (Hematological Malignancy) 03/2020
1	Communicable Diseases (Infectious Diseases) 01/2018
1	Human Influenza (Influenza) 10/2016
1	Tertiary Lymphoid Structures 01/2016
1	Lymphoma (Lymphomas) 03/2015
1	Atrial Fibrillation 09/2012
1	Secondary Hyperparathyroidism 09/2012
1	Ehlers-Danlos Syndrome (Syndrome, Ehlers-Danlos) 11/2011
1	Hypogonadism (Hypergonadotropic Hypogonadism) 10/2011
1	Contact Dermatitis (Eczema, Contact) 07/2011
1	Leukemia 07/2007
1	Heart Failure 04/2006
1	Hypertension (High Blood Pressure) 04/2006
1	Cardiomegaly (Heart Hypertrophy) 04/2006
1	Fibrosis (Cirrhosis) 04/2006
1	Carcinogenesis 03/2003

Drug/Important Bio-Agent (IBA)

7	AntigensIBA 01/2024 - 01/2015
4	VaccinesIBA 01/2024 - 01/2018
3	CytokinesIBA 10/2023 - 07/2011
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 06/2023 - 01/2015
2	LigandsIBA 03/2022 - 01/2018
2	zinc-binding protein (zinc binding protein)IBA 11/2011 - 06/2009
2	ErbB Receptors (EGF Receptor)IBA 07/2007 - 03/2003
1	Therapeutic UsesIBA 01/2024
1	Messenger RNA (mRNA)IBA 01/2024
1	EpitopesIBA 01/2024
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2024
1	Prostate-Specific Antigen (Semenogelase)IBA 01/2024
1	prostatic acid phosphataseIBA 01/2024
1	Galactosylceramides (Galactocerebrosides)IBA 01/2024
1	LipidsIBA 10/2023
1	ChemokinesIBA 10/2023
1	Immune Checkpoint InhibitorsIBA 10/2023
1	Neutralizing AntibodiesIBA 11/2022
1	Chimeric Antigen ReceptorsIBA 03/2020
1	Granzymes (Granzyme)IBA 01/2019
1	Interleukin-6 (Interleukin 6)IBA 01/2019
1	PerforinIBA 01/2019
1	Hemagglutinins (Hemagglutinin)IBA 10/2016
1	HLA-DR Antigens (HLA-DR)IBA 03/2015
1	dinitrophenyl-bovine serum albuminIBA 04/2014
1	Serum AlbuminIBA 09/2012
1	Staphylococcal Protein A (Protein A)IBA 11/2011
1	Proteins (Proteins, Gene)FDA Link 11/2011
1	ZincIBA 10/2011
1	Trace Elements (Biometals)IBA 10/2011
1	Tyrosine (L-Tyrosine)FDA Link 07/2007
1	cimaglerminIBA 07/2007
1	Epidermal Growth Factor (EGF)IBA 07/2007
1	ethylenediamine (ethylenediamine dihydroiodide)FDA Link 07/2006
1	Chelating AgentsIBA 07/2006
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2006
1	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 04/2006
1	Nitric Oxide Synthase (NO Synthase)IBA 04/2006
1	NG-Nitroarginine Methyl Ester (L-NAME)IBA 04/2006
1	Mineralocorticoid Receptor AntagonistsIBA 04/2006
1	AldosteroneIBA 04/2006
1	Eplerenone (Inspra)FDA LinkGeneric 04/2006
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 03/2003
1	AgarIBA 03/2003

Therapy/Procedure

8	Immunotherapy 01/2024 - 01/2015
6	Therapeutics 01/2024 - 01/2015
1	Renal Dialysis (Hemodialysis) 09/2012
1	Parathyroidectomy 09/2012